Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents
Select all:
glb
stl
wrl
x3d
png
6N3N-ribbon-secondary-vis_NIH3D
Select all:
glb
stl
wrl
x3d
png
6N3N-ribbon-rainbow-vis_NIH3D
Select all:
glb
stl
wrl
x3d
png
6N3N-ribbon-bychain-vis_NIH3D
Select all:
glb
stl
wrl
x3d
png
6N3N-ribbon-vis_NIH3D
Select all:
glb
stl
wrl
x3d
png
6N3N-ribbon-secondary-print_NIH3D
Select all:
glb
stl
wrl
x3d
png
6N3N-ribbon-rainbow-print_NIH3D
Select all:
glb
stl
wrl
x3d
png
6N3N-ribbon-bychain-print_NIH3D
Select all:
glb
stl
wrl
x3d
png
6N3N-ribbon-print_NIH3D
Select all:
glb
stl
wrl
x3d
png
6N3N-surf-bychain-print_NIH3D
Select all:
glb
stl
wrl
x3d
png
6N3N-surf-hydropathy-print_NIH3D
Select all:
glb
stl
wrl
x3d
png
6N3N-surf-coulombic-print_NIH3D
Select all:
glb
stl
wrl
x3d
png
6N3N-surf-print_NIH3D
Select all:
glb
stl
wrl
x3d
png